Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Adenocarcinoma Of Kidney

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Adenocarcinoma Of Kidney in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research Excerpts

ExcerptRelevanceReference
"YC-1 displayed cytotoxicity in renal carcinoma cells at 10(-7)-10(-8) M."1.35YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway. ( Chang, YL; Chen, TH; Guh, JH; Huang, DY; Kuo, SC; Lee, FY; Liao, CH; Pan, SL; Teng, CM; Wu, SY, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, SY1
Pan, SL1
Chen, TH1
Liao, CH1
Huang, DY1
Guh, JH1
Chang, YL1
Kuo, SC1
Lee, FY1
Teng, CM1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Adenocarcinoma Of Kidney

ArticleYear
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway.
    British journal of pharmacology, 2008, Volume: 155, Issue:4

    Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Caspase 8; Chromatin; Dose-Response Relationsh

2008